How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Medical Decision Support Systems for Sepsis Market
- By Product Type: Standalone Sepsis Decision Support Software, Integrated Clinical Decision Support Modules, Sepsis Early Warning Systems, Predictive Analytics Platforms for Sepsis, Sepsis Alert and Notification Systems
- By Deployment Mode: On-Premise Solutions, Cloud-Based Solutions, Hybrid Deployment
- By End User: Hospitals and Healthcare Systems, Intensive Care Units (ICUs), Emergency Departments, Outpatient Clinics, Long-Term Care Facilities
- By Data Source Integration: Electronic Health Records (EHR) Integration, Laboratory Information Systems (LIS) Integration, Medical Device Data Integration, Pharmacy Information Systems Integration
- By Algorithm Type: Rule-Based Algorithms, Machine Learning-Based Algorithms, Hybrid Algorithms
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Standalone Sepsis Decision Support Software leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 293 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.178 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.186 →
Full report · locked preview
Everything inside the Medical Decision Support Systems for Sepsis Market report
A complete, evidence-based study - 12 chapters and 123 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Product Type 5
Deployment Mode 3
End User 5
Data Source Integration 4
Algorithm Type 3
Companies profiled
Cerner Corporation (now part of Oracle Corporation)
Epic Systems Corporation
Philips Healthcare
IBM Watson Health
Siemens Healthineers
GE Healthcare
Medtronic
Allscripts Healthcare Solutions
McKesson Corporation
Zynx Health (a part of Hearst Health)
Wolters Kluwer Health
Infermedica
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Cerner Corporation (now part of Oracle Corporation)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Epic Systems Corporation
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Philips Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →IBM Watson Health
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Siemens Healthineers
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →GE Healthcare
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Medtronic
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Allscripts Healthcare Solutions
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →McKesson Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Zynx Health (a part of Hearst Health)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Wolters Kluwer Health
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Infermedica
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →BioMérieux
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →T2 Biosystems
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Biofourmis
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$7,097M by 2033 · 3.5% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Standalone Sepsis Decision Support Software56.0
- Integrated Clinical Decision Support Modules12.4
- Sepsis Early Warning Systems13.1
- Predictive Analytics Platforms for Sepsis8.9
- Sepsis Alert and Notification Systems9.5
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,781M → $2,331M · 3.4%
Europe$1,241M → $1,569M · 3.0%
Asia Pacific$1,133M → $1,648M · 4.8%
Latin America$701.5M → $836.6M · 2.2%
Middle East and Africa$539.7M → $729.7M · 3.8%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →3.442026
3.452027
3.462028
3.472029
3.492030
3.502031
3.512032
3.532033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Cerner Corporation (now part of Oracle Corporation)13.5
- Epic Systems Corporation10.5
- Philips Healthcare13.0
- IBM Watson Health11.5
- Siemens Healthineers11.5
- GE Healthcare12.1
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type13.2%
Deployment Mode29.5%
End User31.2%
Data Source Integration12.9%
Algorithm Type13.3%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.8
- Europe22.0
- Asia Pacific23.2
- Latin America11.8
- Middle East and Africa10.3
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Cerner Corporation (now part of Oracle Corporation) | 78 | 93 | 85 | 90 | 84 | 77 | 85 |
| Epic Systems Corporation | 81 | 78 | 80 | 81 | 82 | 91 | 82 |
| Philips Healthcare | 86 | 69 | 84 | 81 | 78 | 80 | 80 |
| IBM Watson Health | 62 | 68 | 61 | 58 | 73 | 81 | 67 |
| Siemens Healthineers | 76 | 66 | 63 | 72 | 65 | 70 | 69 |
| GE Healthcare | 69 | 58 | 61 | 65 | 46 | 61 | 60 |
| Medtronic | 44 | 40 | 62 | 64 | 53 | 43 | 51 |
| Allscripts Healthcare Solutions | 41 | 49 | 42 | 44 | 49 | 59 | 47 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Cerner Corporation (now part of Oracle Corporation)
- Epic Systems Corporation
- Philips Healthcare
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Cerner Corporation (now part of Oracle Corporation) | ◐ | ✓ | ✓ | ✓ | ✓ | ◐ |
| Epic Systems Corporation | ✓ | ◐ | ✓ | ◐ | ✓ | ✓ |
| Philips Healthcare | ✓ | ✓ | ◐ | ◐ | ◐ | ◐ |
| IBM Watson Health | ◐ | − | ◐ | ◐ | ◐ | ✓ |
| Siemens Healthineers | ✓ | ◐ | − | ◐ | ◐ | − |
| GE Healthcare | − | ◐ | ✓ | ◐ | − | ◐ |
| Medtronic | − | − | ◐ | ◐ | − | ◐ |
| Allscripts Healthcare Solutions | − | ◐ | − | − | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Cerner Corporation (now part of Oracle Corporation)85
2Epic Systems Corporation82
3Philips Healthcare80
4Siemens Healthineers69
5IBM Watson Health67
6GE Healthcare60
7Medtronic51
8Allscripts Healthcare Solutions47
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
Cerner Corporation (now part of Oracle Corporation)Epic Systems CorporationPhilips Healthcare
Challenger2
Strong scale, closing on the leaders.
IBM Watson HealthSiemens Healthineers
Contender1
Focused players with pockets of strength.
GE Healthcare
Niche2
Specialists in a single segment or region.
MedtronicAllscripts Healthcare Solutions
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Type in North America, then scale across Medical Decision Support Systems for Sepsis Market — a $437M beachhead inside a $5.86B market.
Beachhead (SOM)$437Mobtainable near-term
Serviceable (SAM)$2.36Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion90 fit
Standalone Sepsis Decision Support Software
Best fit — highest urgency & budget in Product Type.
Economic buyer78 fit
Integrated Clinical Decision Support Modules
Strong fit — clear ROI and a fast path to value.
End user65 fit
Sepsis Early Warning Systems
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Deployment Mode & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales42%
Partner / channel28%
Digital / self-serve23%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Medical Decision Support Systems for Sepsis Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified41%
Sales qualified25%
Evaluation15%
Closed-won6%
$10.9KCAC
$56KLTV
5.1:1LTV : CAC
< 2 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Medical Decision Support Systems for Sepsis Market is a resilient opportunity — $4.46B by 2033, compounding at 3.4%.
TAM · 2025$3.40Btoday
TAM · 2033$4.46Bforecast
CAGR3.4%2027–2033
Cumulative$35.2Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$4.46BTotal addressable market
SAM$1.68BServiceable available market
SOM$359MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →3.4% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$4.46BLarge & growingTAM by 2033 at 3.4% CAGR
$1.68BServiceable nowreachable with today’s model
$359MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$3.48BBear2.2% CAGR
$4.46BBase3.4% CAGR
$5.70BBull4.5% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Deployment Mode optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Medical Decision Support Systems for Sepsis Market — a $957M market by 2033. Plan: grow share from 5.4% to 11.7%.
Market size · 2033$957Mtotal addressable
Market CAGR11.0%2027–2033
Target share11.7%from 5.4% today
Revenue ambition$112Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 5.4% | 11.7% | At risk |
| Revenue | $56M | $112M | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | At risk |
| Gross margin | 33.2% | 44.2% | At risk |
| Customer retention | 90.3% | 92.9% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Deployment Mode capability
A defensible second engine — invest in Deployment Mode to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Deployment Mode
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $15M capacity & capability investment
- Greenlight bolt-on M&A in Deployment Mode
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossBehind
- Input-cost & supply riskBehind
- Regulatory / policy changeAhead
- Execution & talentAhead
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Medical Decision Support Systems for Sepsis Market conversation — a $5.76B market you can size, segment and defend in minutes.
Market size · 2033$5.76Btotal opportunity
Growth8.0%CAGR to 2033
Addressable buyers1,737+accounts in scope
Typical ROI4.4×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.4×return on cost, year one
< 2 mopayback period
$78K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Cerner Corporation (now part of Oracle Corporation)Epic Systems CorporationPhilips HealthcareIBM Watson HealthSiemens HealthineersGE HealthcareMedtronicAllscripts Healthcare Solutions+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Medical Decision Support Systems for Sepsis Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Medical Decision Support Systems for Sepsis Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Pharma-grade Synthetic Camphor Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportHGH Biosimilars Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportHepatocellular Carcinoma Drug Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportWhole Cell Cholera Vaccine Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportAir Polishing Device Market
Market size, share, segmentation and regional forecast.
$719M market · 2025 base year
View reportMethotrexate Oral Solution Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportSprycel Market
Market size, share, segmentation and regional forecast.
$3.8B market · 2025 base year
View reportSickle Cell Disease Therapeutics Market
Market size, share, segmentation and regional forecast.
$5.5B market · 2025 base year
View reportRetinal Disorders Treatment Market
Market size, share, segmentation and regional forecast.
$6.2B market · 2025 base year
View reportRetinal Drugs and Biologics Market
Market size, share, segmentation and regional forecast.
$5.1B market · 2025 base year
View reportRemicade Biosimilar Market
Market size, share, segmentation and regional forecast.
$6.3B market · 2025 base year
View reportTemporary Artificial Skin Market
Market size, share, segmentation and regional forecast.
$4.9B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.